Missouri lawmakers have approved a GOP-led bill in committee to promote research into the therapeutic potential of certain psychedelics such as psilocybin, MDMA and ketamine.
The panel was initially scheduled to also take up an additional measure to provide legal protections to people using psilocybin for medical reasons, but that more far-reaching proposal was removed from consideration.
The House Veterans Committee approved HB 1154 from Rep. Dan Houx (R) in a 11-0 vote, just about a week after holding a hearing at which members took testimony on the two reform proposals.
“There’s been extensive research done on this. This has changed people’s lives with a very short treatment,” Houx said at last week’s hearing. “This is not an ongoing treatment. It’s very few sessions that cures a situation.”
Chairman Dave Griffith (R) said on Tuesday that he never expected he’d oversee the advancement of legislation on the issue.
“If you would have told me five years ago that I would be chairing a committee and hearing a bill…about psychedelics for veterans, I would have told you you’re crazy,” he said.
Here’s what Houx’s HB 1154 would accomplish:
The measure would would authorize a research partnership between the state Department of
Read full article on Marijuana Moment
